BOSTON, March 15, 2016 /PRNewswire/ -- Medisafe®, the personalized mHealth platform for medication management, announced today a new collaboration with Nestlé Health Science, a health science company that is advancing the role of nutritional therapy to improve patient health. The partnership aims to realize the proven benefits of compliance to the proper regimen of IMPACT ADVANCED RECOVERY Specialized Nutrition Drink to address the unique nutritional needs of major elective surgery patients at risk of infection.
The companies will work with clinical teams at a number of major hospital systems across the U.S. to help patients install Medisafe on their smart devices when their treating physicians recommend IMPACT ADVANCED RECOVERY Drink. Patients who have received a recommendation from their healthcare professionals to consume IMPACT ADVANCED RECOVERY Drink will receive Medisafe alerts reminding them when it's time for each recommended serving. It will also display educational content provided by Nestlé Health Science. They will also have access to all Medisafe features and functionality, including management of any medications, "Medfriend" caregiver support, and a feed of additional content and resources tailored to their individual circumstances.
This collaboration with Nestlé Health Science initially focuses on the five-to-ten day perioperative window (before and after surgery) for major elective surgery patients.
"Partnering with Nestlé Health Science is one in a series of initiatives that will make Medisafe available to healthcare providers so that they can help people take more control of their health," said Jon Michaeli, Medisafe's EVP Marketing and Business Development. "This partnership comes on the heels of our recent Medisafe Providers launch, showing our commitment to build tools within the platform for physicians and care teams to support their patients' compliance on an ongoing basis."
The potential benefit of the Medisafe/Nestlé Health Science joint offering is substantial. "In study after study, strong compliance to IMPACT® formulas in the perioperative protocol has been shown to support the immune system to help promote recovery after major elective surgery," said Hoddy Klein, Vice President of Medical Nutrition Marketing North America for Nestlé Health Science. "We believe the Medisafe application has the potential to significantly increase adherence to the IMPACT protocol that is recommended for certain major elective surgery patients by their healthcare professionals, and we look forward to seeing the positive results of this collaboration in the months ahead."
Medisafe is the personalized medication management platform that helps patients stay on top of all their medications. More than just a pill organizer and reminder, Medisafe makes it easy to adhere to the most complicated medication schedules, enables care collaboration between a patient, their loved ones and physicians, and delivers content and services tailored to specific conditions and situations. Medisafe's over 2.5 million users have recorded over 300 million successful medication doses on their iOS and Android smartphones and tablets, leading to 100,000 user reviews that average 4.5 out of 5 stars in the iTunes and Google Play app stores.
About Nestlé Health Science
Nestlé Health Science, a wholly-owned subsidiary of Nestlé, is a health-science company engaged in advancing the role of nutritional therapy to change the course of health for consumers, patients and its partners in healthcare. Nestlé Health Science's portfolio of nutrition solutions, diagnostics, devices and drugs targets a number of health areas, such as inborn errors of metabolism, pediatric and acute care, obesity care, healthy aging as well as gastrointestinal and brain health. Nestlé Health Science employs around 3,000 people worldwide and is headquartered in Epalinges (near Lausanne), Switzerland.